Evidence map›Paper›PMID 11157740›Full record

ArticleThe EMBO journal2001

A plastid segregation defect in the protozoan parasite Toxoplasma gondii.

C Y He, M K Shaw, C H Pletcher, B Striepen, L G Tilney, D S Roos

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 171 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Microbiology spectrum · 2022
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Journal of lipid research · 2018
    Article
  12. AFrontiers in immunology · 2018
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. The apicoplast: now you see it, now you don't.International journal for parasitology · 2017
    Review
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

C Y HeDepartment of Biology, 305 Goddard Laboratories, University of Pennsylvania, Philadelphia, PA 19104, USA.
M K Shaw
C H Pletcher
B Striepen
L G Tilney
D S Roos
University of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Apicomplexan parasites--including the causative agents of malaria (Plasmodium sp.) and toxoplasmosis (Toxoplasma gondii)--harbor a secondary endosymbiotic plastid, acquired by lateral genetic transfer from a eukaryotic alga. The apicoplast has attracted considerable attention, both as an evolutionary novelty and as a potential target for chemotherapy. We report a recombinant fusion (between a nuclear-encoded apicoplast protein, the green fluorescent protein and a rhoptry protein) that targets to the apicoplast but grossly alters its morphology, preventing organellar segregation during parasite division. Apicoplast-deficient parasites replicate normally in the first infectious cycle and can be isolated by fluorescence-activated cell sorting, but die in the subsequent host cell, confirming the 'delayed death' phenotype previously described pharmacologically, and validating the apicoplast as essential for parasite viability.

Indexed as

AnimalsEukaryotaGenes, ProtozoanGreen Fluorescent ProteinsLuminescent ProteinsMembrane ProteinsMicroscopy, ElectronMutationPhenotypePlastidsProtozoan ProteinsRecombinant Fusion ProteinsSymbiosisToxoplasmaGreen Fluorescent ProteinsLuminescent ProteinsMembrane ProteinsProtozoan ProteinsRecombinant Fusion ProteinsROP 1 protein, Toxoplasma gondii

Identifiers

PMID11157740
PMCPMC133478
OpenAlexW2009690860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.